Oorsprong van het eerstegraads netwerk van Jerome Goldstein
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jerome Goldstein via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | President | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| Washington University in St. Louis | College/University | Doctorate Degree | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ALERE INC | Medical Specialties | Chief Executive Officer | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NETMED, INC. | Medical Specialties | President | |
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Director/Board Member | |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director/Board Member | |
Tom's of Maine, Inc.
 Tom's of Maine, Inc. Household/Personal CareConsumer Non-Durables Tom's of Maine, Inc. manufactures and markets personal care products. It provides natural products for hair, teeth, skin and cold care. It also manufactures antiperspirants, soaps, shampoos and shaving cream made from natural ingredients. The company was founded in 1970 by Tom Chappell and Kate Chappell and is headquartered in Kennebunk, ME. | Household/Personal Care | Director of Finance/CFO | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| VISTERRA INC | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
Fenway Pharmaceuticals, Inc.
 Fenway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fenway Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It provides drug development services. The company is headquartered in Newton, MA | Pharmaceuticals: Major | Chief Executive Officer | |
| TESARO INC | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
| Boston University | College/University | Doctorate Degree Undergraduate Degree | |
| Bentley University | College/University | Director/Board Member | |
| Trinity College (Connecticut) | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Graduate Degree | |
| University of Maryland | College/University | Corporate Officer/Principal | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| E. R. Squibb & Sons LLC | Chief Tech/Sci/R&D Officer | ||
| E.R. Squibb & Sons Research & Development | Director/Board Member | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Operating Officer | |
| IGM BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
Thousand Oaks Corp.
 Thousand Oaks Corp. Wholesale DistributorsDistribution Services Thousand Oaks Corp. is an American company that wholesales sporting goods. | Wholesale Distributors | Corporate Officer/Principal | |
Hopewell Therapeutics, Inc.
 Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer | |
| ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Verenigd Koninkrijk | 2 |
| Israël | 2 |
| Frankrijk | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 36 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
| Distribution Services | 2 |
Operationeel
| Director/Board Member | 78 |
| Chairman | 31 |
| Independent Dir/Board Member | 30 |
| President | 22 |
| Director of Finance/CFO | 18 |
Sterkste connecties
| Insiders | |
|---|---|
| Davey Scoon | 24 |
| Brian Pereira | 23 |
| David Arkowitz | 20 |
| Mark B. Skaletsky | 18 |
| Ron Zwanziger | 15 |
| Michael Narachi | 14 |
| Michael Loberg | 13 |
| Louis Brenner | 12 |
| Joseph Farmer | 10 |
| Edward C. English | 7 |
| E. Scott Toner | 7 |
| Timothy G. Healey | 6 |
| Jerome M. Lewis | 5 |
| Michael N. Avallone | 2 |
- Beurs
- Insiders
- Jerome Goldstein
- Bedrijfsconnecties
